Clinical trial management system that gives research sites study, finance, and stipend workflows in one platform.
Clinical Research IO
Health tech firm, CRIO, revolutionizes clinical trials with integrated eSource and CTMS solutions.
Founded
2016Health tech firm, CRIO, revolutionizes clinical trials with integrated eSource and CTMS solutions.
Founded by a site owner, Clinical Research IO (CRIO) is a health tech company dedicated to revolutionizing clinical trials. Their core mission is to streamline and modernize trial studies through integrated software solutions. CRIO offers a comprehensive suite of products, including eSource, CTMS, eConsent, and patient stipend solutions, designed to enhance efficiency and data accuracy in clinical research. Their market focus spans single sites, research networks, academic institutions, and sponsors seeking faster, more reliable data collection.
CRIO has garnered attention for its innovative approach to clinical trials, attracting notable investors and industry experts. The company has achieved significant milestones in improving trial efficiency and reducing costs for research sites and sponsors. By providing a robust, all-in-one platform, CRIO has made a substantial impact on the clinical research landscape, facilitating better data management and compliance across various types of studies.
Companies similar to Clinical Research IO include Clinical.ly, ClinOne, Florence Healthcare and Endpoint Clinical.
Clinical Research IO was founded in 2016.
Clinical Research IO's headquarters is located in Boston, MA, US.
Clinical Research IO's most recent funding round was for $1.8M (USD) in August 2023.
As of Aug 9, 2023, Clinical Research IO has disclosed funding of $19M (USD). Undisclosed round amounts are excluded.
Clinical Research IO has 83 employees as of Feb 5, 2024.
Endpoint Clinical